Latest News

Savara to Join Russell Microcap Index

Savara to Join Russell Microcap Index

June 20, 2017 at 3:05 pm 0 comments

Savara Inc. said early Tuesday it will join the Russell Microcap Index at the conclusion of the Russell indexes annual reconstitution, effective at U.S. market open on June 26. Membership in the Russell Microcap Index, which remains in place for one year, provides automatic inclusion in the appropriate growth and value style indexes, the company said in a press release.Read More

Bob Evans Farms Fiscal Q4 EPS Beats Views

Bob Evans Farms Fiscal Q4 EPS Beats Views

June 15, 2017 at 9:48 am 0 comments

Bob Evans Farms shares were higher nearly 4% in recent pre-market trade after the company reported a fiscal Q4 adjusted earnings from continuing operations of $0.58 per diluted share compared with an income of $0.32 per share a year ago, beating the $0.52 average EPS estimate from analysts polled by Capital IQ. Net sales from continuing operations during the threeRead More

Sonoco Products Restates Price Increase

Sonoco Products Restates Price Increase

June 13, 2017 at 10:48 am 0 comments

Sonoco Products Company restated and is implementing a previously announced price increase for all grades of uncoated recycled paperboard (URB) products in the US and Canada, effective July 10. The company said that the low yield on the previously announced April URB price increase, along with the impact of rising raw material and other costs, makes it necessary to goRead More

Pfizer, Astellas Amend Research Protocol

Pfizer, Astellas Amend Research Protocol

June 9, 2017 at 11:54 am 0 comments

Pfizer and partner Astellas Pharma said pre-market Friday that they have amended the protocol for the registrational PROSPER trial, a double-blind, placebo-controlled study evaluating the efficacy and safety of Xtandi in patients with non-metastatic castration-resistant prostate cancer. The main purpose of the amendment is to revise the plan for the analyses of the primary and several secondary endpoints, which allowsRead More

Cerus Shares Gain

Cerus Shares Gain

June 7, 2017 at 12:03 pm 0 comments

Cerus shares were 10% higher Wednesday after the biomedical products company said that the expected shortage of platelet additive solution from Fresenius Kabi, announced in May, could be less disruptive to the blood center production of the company’s Intercept platelets than initially anticipated. Ceres said this follows a decision by the U.S. Food and Drug Administration to review a recentRead More

Five Prime Therapeutics Unveils Phase 1 Data

Five Prime Therapeutics Unveils Phase 1 Data

June 5, 2017 at 12:57 pm 0 comments

Five Prime Therapeutics said on Saturday that it presented data from a phase 1 trial of FPA 144 for the treatment of gastric cancer, as well as for cabralizumab in patients with pigmented villonodular synovitis (PVNS) at the American Society of Clinical Oncology Annual Meeting in Chicago. Part 2 of the ongoing phase 1 trial of FPA 144 is evaluatingRead More

XBiotech Shares Higher

XBiotech Shares Higher

June 1, 2017 at 11:38 am 0 comments

XBiotech (XBIT) shares were 9% higher Thursday after the company said its phase 3 study on colorectal cancer patients treated with Hutruo, or MABp1, showed improved clinical outcomes, including reduced disease progression and improved survival for those patients that achieved primary endpoint. The company said that in the study, 82% of all patients that received at least one dose ofRead More